Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. GeneDx Holdings Corp shares valued at $1,310,000 were purchased by Feeley Kevin on Apr 09 ’25. At $91.80 per share, Feeley Kevin acquired 14,270 shares.
Also, Stueland Katherine purchased 46,594 shares, netting a total of over 4,100,000 in proceeds.
Before that, Feeley Kevin had sold 8,746 shares from its account. In a trade valued at $836,211, the CHIEF FINANCIAL OFFICER traded GeneDx Holdings Corp shares for $95.61 each. Upon closing the transaction, the insider’s holdings decreased to 8,746 shares, worth approximately $1.56 million.
As published in their initiating research note from Wells Fargo on August 28, 2024, GeneDx Holdings Corp [WGS] has been an Equal weight and the price target has been revised to $34. Analysts at Craig Hallum started covering the stock with ‘”a Buy”‘ outlook in a report released in early July.
Analyzing WGS Stock Performance
During the last five days, there has been a surge of approximately 14.63%. Over the course of the year, GeneDx Holdings Corp shares have jumped approximately 26.58%. Shares of the company reached a 52-week high of $115.60 on 02/19/25 and a 52-week low of $58.62 on 02/07/25. A 50-day SMA is recorded $88.86, while a 200-day SMA reached $62.84.
Support And Resistance Levels for GeneDx Holdings Corp (WGS)
According to the 24-hour chart, there is a support level at 86.03, which, if violated, would cause prices to drop to 74.78. In the upper region, resistance lies at 103.09. The next price resistance is at 108.90. RSI (Relative Strength Index) is 56.32 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.90, which suggests the price will decrease in the coming days. Percent R is at 29.86%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
